κ-Opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 2, 1996, Pages 545-554

  Shippenberg, T S ^a   Lefevour, A ^a   Heidbreder, Ch ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; BENZENEACETAMIDE DERIVATIVE; COCAINE; DOPAMINE; DRUG DERIVATIVE; KAPPA OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALTREXONE; NORBINALTORPHIMINE; PYRROLIDINE DERIVATIVE;

ANIMAL; ARTICLE; CONDITIONING; DRUG EFFECT; DRUG POTENTIATION; MALE; RAT; REWARD; SECRETION; SPRAGUE DAWLEY RAT;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; BENZENEACETAMIDES; COCAINE; CONDITIONING (PSYCHOLOGY); DOPAMINE; MALE; NALTREXONE; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; REWARD;

EID: 0030087946     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. ACKERMAN, J. M. AND WHITE, F. L.: A10 somatodendritic dopamine autoreceptor sensitivity following withdrawal from repeated cocaine treatment. Neurosci. Lett. 117: 181-187, 1990.
2. BROWN, E. C. AND FIBIGER, H. C.: Differential effects of excitotoxic lesions of the amygdala on cocaine-induced conditioned locomotion and conditioned place preference. Psychopharmacology 113: 123-130, 1993
3. CHAVKIN, C., JAMES, I. F. AND GOLDSTEIN, A.: Dynorphin is a specific endogenous ligand of the κ-opioid receptor. Science 215: 413-415, 1982.
4. DAHLSTROM, A. AND FUXE, K., Evidence for the existence of monoamine containing neurons in the central nervous system. I. demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol. Scand. 232: 1-55, 1965
5. DAUNAIS, J B., ROBERTS, D. C. S. AND MCGINTY, J. F.: Cocaine self-administration increases prodynorphin, but not c-fos m RNA in rat striatum. Neuroreport 4: 543-546, 1993.
6. DAVIS, W. M AND SMITH, S. G.: Role of conditioned reinforcers in the initiation, maintenance and extinction of drug-seeking behavior. Pavlovian J. Biol. Sci. 11: 1151-1152, 1976.
7. DE WIT, H. AND STEWART, J. M.: Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology 75: 134-143, 1981.
8. DE WIT, H. AND STEWART, J. M.: Reinstatement of heroin-reinforced responding in the rat. Psychopharmacology 79: 29-31, 1983.
9. DEVINE, D. P., LEONE, P., POCOCK, D. AND WISE, R. A.: Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: In-vivo microdialysis studies. J. Pharmacol Exp. Ther. 266: 1236-1246, 1993.
10. D. I. CHIARA, G. AND IMPERATO, A.: Opposite effects of μ- and κ-opioid agonists on dopamine release in the nucleus accumbens and dorsal caudate of freelymoving rats. J Pharmacol. Exp. Ther. 244: 1067-1080, 1988a.
11. D. I. CHIARA, G. AND IMPERATO, A.: Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U.S.A. 85: 5274-5278, 1988b.
12. EHRMAN, R. N., ROBBINS, S. J., CHILDRESS, A. R. AND O' BRIEN, C : Conditioned responses to cocaine-related stimuli in cocaine abuse patients. Psychopharmacology 107: 523-529, 1992.
13. GAWIN, F. H. AND ELLINWOOD, E. H.: Cocaine and other stimulants. N. Engl. J. Med. 318: 1173-1182, 1988.
14. GAWIN, F. H. AND KLEBER, H. D.: Abstinence symptomology and psychiatric diagnosis in cocaine abusers. Arch. Gen Psych. 43: 107-113, 1986.
15. HEIDBREDER, C. A., GOLDBERG, S. R. AND SHIPPENBERG, T S.: The κ-opioid receptor agonists U69593 attenuates cocaine-induced behavioral sensitization in the rat. Brain Res. 616: 333-338, 1993.
16. HEIDBREDER, C. A. AND SHIPPENBERG, T. S.: U69593 prevents cocaine sensitization by normalizing basal accumbes dopamine. Neuroreport 5: 1797-1800, 1994.
17. HEIDBREDER, C. A. AND SHIPPENBERG, T. S.: Sensitization to the the conditioned rewarding effects of cocaine. In Problems of Drug Dependence, 1994: Proceedingsof the 55th Ann Meeting The College on Problems of Drug Dependence, ed. by L. S. Harris, Palm Beach, FL, in press.
18. HEIDBREDER CH., BABOVIC-VUKSANOVIC D., SHOAIB M., SHTPPENBERG T. S.: Development of behavioral sensitization to cocaine: Influence of κ-opioid receptor agonists. J. Pharmacol. Exp. Ther. 275: 150-163, 1995.
19. HENRY, D. J. AND WHITE, F. J.: Electrophysiological correlates of psychomotor stimulant-induced sensitization. In The Neurobiology of Drug and Alcohol Addiction, ed. by P. W. Kalivas and H. H Samson, pp. 88-100, The New York Academy of Sciences, New York, 1991.
20. HORAN, P., TAYLOR, H., YAMAURA, H. I. AND PORRECA, F.: Extremely long-lasting antagonistic actions of nor-binaltorphimine in the mouse tail-flick test. J. Pharmacol Exp. Therap. 260: 1237-1243, 1992.
21. HURD, Y. L , BROWN, E E., FINLAY, J. M., FIBIGER, H. C. AND GERFERN, C. R.: Cocaine self-administration differentially alters mRNA expression of striatal peptides. Mol. Brain Res. 13: 165-170, 1992.
22. HURD, Y. L. AND HERKENHAM, M.: Molecular alterations in the neostriatum of human cocaine addicts. Synapse 13: 357-369, 1993.
23. KALIVAS, P. W.: Interactions between dopamine and excitatory ammo acids in behavioral sensitization to psychostimulants. Drug Alcohol Dependence 37: 95-100, 1995.
24. KALIVAS, P. W. AND STEWART, J.: Dopamine transmission in the initiation and expression of drug and stress induced sensitization. Brain Res. Rev. 16: 223-244, 1991.
25. KALIVAS, P. W. AND DUFFY, P.: Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J. Neurosci. 131: 266-275, 1993.
26. 3H] U69593, a highly selective ligand for the κ-opioid receptor. Eur. J. Pharmacol. 109: 281-284, 1985.
27. LAHTI, R. A, VON VOIGHTLANDER, P. F. AND BARSUHN, C.: Properties of a selective kappa agonist U-50488H. Life Sci. 31: 2257-2260, 1982.
28. LETT, B. T.: Repeated exposure intensify rather than diminish the rewarding effects of amphetamine, morphine and cocaine. Psychopharmacology 98: 357-362, 1989.
29. MORENCY, M. A AND BENINGER, R. J.: Dopaminergic substrates of cocaine induced place conditioning. Brain Res 399: 33-41, 1986.
30. MUCHA, R. F. AND HERZ, A.: Motivational propetires of κ- and μ-opioid receptor agonists studies with place and taste preference conditioning procedures. Psychopharmacology 82: 241-247, 1985
31. NOMIKOS, G. AND SPYRAKI, C.: Cocaine-induced place conditioning: importance of route of administration and other procedural variables. Psychopharmacology 94: 119-125, 1988.
32. O'BRIEN, C. P., CHILDRESS, A. R., MCLELLAN, T. AND EHRMAN, R.: Integrating systematic cue exposure with standard treatment in recovering drug dependent patients. Addictive Behaviors 15: 355-365, 1990.
33. PAXINOS, G. AND WATSON, C : The Rat Brain In Stereotaxic Coordinates. Academic Press, Sydney, 1982.
34. PORTOGHESE, P. S., LIPKOWSKI, A. W. AND TAKEMOKI, A. E.: Binaltorphimine and norbinaltorphimine, potent and selective κ-opioid receptor antagonists. Life Sci. 40: 1287-1292, 1987.
35. PFEIFFER, A., BRANTL, V., HERZ, A. AND EMRICH, H G.: Psychotomimesis mediated by κ-opiate receptors. Science 233: 774-776, 1986.
36. ROBERTS, D. C. S.: Neural substrates mediating cocaine reinforcement; the role of monamine systems. In Cocaine, Pharmacology, Physiology and Clinical Studies, ed. by J. M. Lakkoaki, M. P. Galloway and F. J White, pp. 73-90, 1992.
37. ROBINSON, T. E. AND BERRIDGE, K. C.: The neural basis of drug-craving: An incentive-sensitization theory of addiction Brain Res. Rev. 18: 247-291, 1993
38. SCHECTER, M. D. AND CALCAGNETTI, D. J.: Trends in place preference conditioning with a cross-indexed bibliography; 1957-1991 Neurosci. Biobehavioral Rev. 17: 21-41, 1993.
39. SHIPPENBERG, T. S. AND HERZ, A.: Motivational effects of opioids: Influence of D-1 versus D-2 receptor antagonists. Eur. J. Pharmacol. 151: 233-243, 1988.
40. SHIPPENBERG, T. S., MILLAN, M. J., MUCHA, R. F AND HERZ, A.: Involvement of β-endorphin and μ-opioid receptors in mediating the aversice effect of lithium in the rat. Eur. J. Pharmacol. 154: 135-144, 1988.
41. SHIPPENBERG, T. S., R. BALS-KUBIK, AND HERZ, A., Examination of the neurochemical substrates mediating the motivational effects of opioids: Role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. J. Pharmacol. Exp. Therap. 265: 53-59, 1993.
42. SHIPPENBERG, T. S., HERZ, A., SPANAGEL, R., BALS-KUBIK, R. AND STEIN C.: Conditioning of opioid reinforcement: Neuroanatomical and neurochemical substrates, In The Neurobiology of Drug And Alcohol Addiction, ed. by P. W. Kalivas and H. H. Samson, pp. 347-357, New York Academy of Sciences, New York, 1992.
43. SHIPPENBERG, T. S. AND HEIDBREDER, C. H.: Sensitization to the conditioned rewarding effects of cocaine: Pharmacological and temporal aspects. J. Pharmacol. Exp. Ther. 273: 808-815, 1995.
44. SPANAGEL, R., HERZ, A. AND SHIPPENBERG, T. S.: Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. U.S.A. 89: 2046-2050, 1992.
45. SPANAGEL, R., ALMEIDA, O. F. X. AND SHIPPENBERG, T. S.: Evidence that norbinaltorphimine (nor-BNI) functions as an antagonist at multiple opioid receptor types. Eur. J. Pharmacol. 264: 157-163, 1994.
46. SMILEY, P. L., JOHNSON, M., BUSH, L., GIBB, J. W. AND HANSON, G. R.: Effects of cocaine on extrapyramidal and limbic dynorphin systems. J. Pharmacol. Exp. Ther. 253: 938-943, 1990.
47. SPANGLER, R., UNTERWALD, E. M. AND KREEK, M. J.: "Binge" cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudateputamen. Mol. Br. Res. 19: 323-327, 1993.
48. SPEALMAN, R. D. AND BERGMAN, J.: Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids. J. Pharmacol. Exp. Therap. 261: 607-615, 1992.
49. SPEALMAN, R. D. AND BERGMAN, J.: Opioid modulation of the discriminative stimulus effects of cocaine: comparison of μ, κ and δ agonists in squirrel monkeys discriminating low doses of cocaine. Behavioral Pharmacol. 5: 21-31, 1994.
50. STEWART, J. AND BADIANI, A.: Tolerance and sensitization to the behavioral effects of drugs. Behav. Pharmacol. 4: 289-313, 1993.
51. SWANSON, L. W.: The projection of the ventral tegmental area and adjacent regions: A combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res. Bull. 9: 321-353, 1982.
52. UKAI, M., KAMIYA, T., TOYOSHI, T. AND KAMEYAMA, T : Systemic administration of dynorphin A-(1-13) markedly inhibits different behavioral responses induced by cocaine in the mouse. Neuropharmacology 31: 843-849, 1979.
53. WEISS, F., MARKOU, A., LORANG, M. T. AND KOOB, G. F.: Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res. 593:314-318, 1992a.
54. WEISS, F., PAULUS, M. P., LORANG, M. T. AND KOOB, G. F.: Increases in extracellular dopamine in the nucleus accumbens by cocaine are inversely related to basal levels: Effects of acute and repeated administration. J. Neurosci. 12: 4372-4380, 1992b.
55. WISE, R. A. AND ROMPRE, P. P.: Brain dopamine and reward. Ann. Rev. Psychol. 40: 191-225, 1989.
56. WITHERS, N. W., PULVIRENTI, L., KOOB, G. F. AND GILLIN, J. C.: Cocaine abuse and dependence. J Clin. Psychopharmacol. 15: 63-78, 1995.